Overview
Nexstim is a Finnish medical technology company specializing in navigated brain stimulation, offering the NBS System for neurosurgical planning and the NBT System for treating major depressive disorder with TMS. Their proprietary eXimia technology provides precise, image-guided transcranial magnetic stimulation.
More in Neuromodulation
Latest industry news
FDA Grants De Novo Approval to Modius Spero Neuromodulation Device for PTSD
2026-09-23 · Policy
Vagus Nerve Stimulation Enters the Sports Performance Arena With New Anxiety Support Device
2026-09-22 · Product
Aurenar Raises $5.7M to Accelerate Stroke Neuromodulation Device Development
2026-09-21 · Funding
UCANACT Raises €800,000 to Advance Brain-Computer Communication Technology
2026-09-20 · Funding
Company details
Category
⚡ Neuromodulation
Location
Helsinki, Finland
Funding
Public · Helsinki Stock Exchange
Website
www.nexstim.comListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →